CRON — Cronos Group Inc · P/E 14, rev $98.2M

Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.

Latest reported CRON revenue for 2026-06-30 was $98.2M. Net income was $45.8M. CRON currently screens at market cap $738.3M and trailing P/E 13.6.

Use this CRON page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRON quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRON SEC filings page. Lician reads the product cache first so this HTML stays unique to Cronos Group Inc even when a live quote feed is slow.

Cronos Group Inc latest statements (FY2025)

Latest cached year on this hub. Full CRON income, balance, and cash tables.

  • Revenue$146.6M
  • Net Income-$9.4M
  • Total Assets$1.20B
  • Total Debt$0
  • Free Cash Flow$51.6M

CRON recent filings